gamma-tocotrienol, plastochromanol 8, plastochromanol 8, plastochromanol 3, tocotrienol, gamma
Name | Gamma-Tocotrienol | ||
PubChem CID | 5282349 | ||
Molecular Weight | 410.6g/mol | ||
Synonyms |
gamma-tocotrienol, plastochromanol 8, plastochromanol 8, plastochromanol 3, tocotrienol, gamma |
||
Formula | C₂₈H₄₂O₂ | ||
SMILES | CC1=C(C=C2CCC(OC2=C1C)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O | ||
InChI | 1S/C28H42O2/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7)18-16-25-19-26(29)23(5)24(6)27(25)30-28/h11,13,15,19,29H,8-10,12,14,16-18H2,1-7H3/b21-13+,22-15+/t28-/m1/s1 | ||
InChIKey | OTXNTMVVOOBZCV-WAZJVIJMSA-N | ||
CAS Number | 14101-61-2 | ||
ChEMBL ID | CHEMBL120697 | ||
ChEBI ID | CHEBI:33277 | ||
KEGG ID | C14155 | ||
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | HongHua | ||
Use Part | Flower | ||
Habitat | HeNan, HuNan, SiChuan, XinJiang, XiZang | ||
Flavor | Pungent | ||
Meridian Tropism | Heart, Liver | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Asterales
-->Family: Asteraceae
-->Genus: Carthamus
-->Species: Carthamus tinctorius
|
Chineses Pinyin | TaoRen | ||
Use Part | Seed | ||
Habitat | BeiJing, ShanDong, Shaanxi, HeNan, LiaoNing | ||
Flavor | Bitter, Sweet | ||
Meridian Tropism | Heart, Liver, Large intestine | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Rosales
-->Family: Rosaceae
-->Genus: Prunus
-->Species: Prunus persica
|
Chineses Pinyin | HuMaYe | ||
Use Part | Leaf | ||
Flavor | Sweet | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Lamiales
-->Family: Pedaliaceae
-->Genus: Sesamum
-->Species: Sesamum indicum
|
Chineses Pinyin | ZongLv | ||
Use Part | Petiole and fibre of sheath | ||
Habitat | HuNan, JiangXi, ZheJiang, FuJian, GuangDong, GuiZhou, YunNan, HaiNan, XiZang, TaiWan | ||
Flavor | Bitter; Astringent | ||
Meridian Tropism | Lung; Liver; Large Intestine | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Arecales
-->Family: Arecaceae
-->Genus: Trachycarpus
-->Species: Trachycarpus fortunei
|
Pair Name | Gamma-Tocotrienol, Etoposide | |||
Partner Name | Etoposide | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
In Vitro Model | MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 |
MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 | |
Result | Our results provide evidence for the profound anti-tumorigenic effect of combined etoposide and γ-tocotrienol in the breast cancer cell lines. |
Pair Name | Gamma-Tocotrienol, Capecitabine | |||
Partner Name | Capecitabine | |||
Disease Info | [ICD-11: 2B72] | Gastric cancer | Investigative | |
Biological Phenomena | Inhibition-->Angiogenesis | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Down-regulation | Expression | BCL-xL | hsa598 | |
Down-regulation | Expression | BIRC5 | hsa332 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | COX2 | hsa4513 | |
Down-regulation | Expression | CXCR4 | hsa7852 | |
Down-regulation | Expression | ICAM1 | hsa3383 | |
Down-regulation | Expression | MMP9 | hsa4318 | |
Up-regulation | Expression | PARP1 | hsa142 | |
Down-regulation | Expression | RELA | hsa5970 | |
Down-regulation | Expression | VEGFA | hsa7422 | |
Down-regulation | Expression | XIAP | hsa331 | |
In Vitro Model | SNU-5 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_0078 |
SNU-16 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_0076 | |
MKN45 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_0434 | |
Result | Our results show that γ-tocotrienol can potentiate the effects of capecitabine through suppression of NF-κB-regulated markers of proliferation, invasion, angiogenesis, and metastasis. |
Pair Name | Gamma-Tocotrienol, SU11274 | |||
Partner Name | SU11274 | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Inhibition-->Epithelial-mesenchymal transition | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Expression | CDH1 | hsa999 | |
Up-regulation | Expression | CTNNB1 | hsa1499 | |
Up-regulation | Expression | KRT18 | hsa3875 | |
Up-regulation | Expression | KRT8 | hsa3856 | |
Down-regulation | Phosphorylation | NFKB1 | hsa4790 | |
Down-regulation | Phosphorylation | PIK3CA | hsa5290 | |
Down-regulation | Phosphorylation | PTEN | hsa5728 | |
Down-regulation | Phosphorylation | STAT1 | hsa6772 | |
Down-regulation | Phosphorylation | STAT5 | hsa6776 | |
Down-regulation | Expression | VIM | hsa7431 | |
In Vitro Model | +SA | The highly malignant +SA cell line was derived from an adenocarcinoma developed spontaneously in a BALB/c female mouse | Mus musculus (Mouse) | N.A. |
Result | Suggest that combined γ-tocotrienol and Met inhibitor treatment may provide benefit in treatment of breast cancers characterized by aberrant Met activity. |
Pair Name | Gamma-Tocotrienol, Gemcitabine | |||
Partner Name | Gemcitabine | |||
Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Down-regulation | Expression | BCL-xL | hsa598 | |
Down-regulation | Expression | BIRC2 | hsa329 | |
Up-regulation | Activity | CASP3 | hsa836 | |
Up-regulation | Activity | CASP9 | hsa842 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | COX2 | hsa4513 | |
Down-regulation | Expression | CXCR4 | hsa7852 | |
Down-regulation | Expression | MMP9 | hsa4318 | |
Down-regulation | Expression | MYC | hsa4609 | |
Down-regulation | Expression | NFKB1 | hsa4790 | |
Down-regulation | Expression | VEGFA | hsa7422 | |
In Vitro Model | MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0428 |
In Vivo Model | MIA PaCa-2 cells (1×10⁶) in 100 µL PBS were injected into the subcapsular region of the pancreas with a 27-gauge needle and a calibrated push button-controlled dispensing device. | |||
Result | Our findings suggest that γ-T3 can inhibit the growth of human pancreatic tumors and sensitize them to gemcitabine by suppressing NF-κB-mediated inflammatory pathways linked to tumorigenesis. |
Pair Name | Gamma-Tocotrienol, Capecitabine | |||
Partner Name | Capecitabine | |||
Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | BIRC2 | hsa329 |
Down-regulation | Expression | BIRC3 | hsa330 | |
Down-regulation | Expression | BIRC5 | hsa332 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | CXCR4 | hsa7852 | |
Down-regulation | Expression | ICAM1 | hsa3383 | |
Down-regulation | Expression | MMP9 | hsa4318 | |
Down-regulation | Expression | MYC | hsa4609 | |
Down-regulation | Expression | NFKB1 | hsa4790 | |
Down-regulation | Expression | VEGFA | hsa7422 | |
In Vitro Model | HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 |
In Vivo Model | Luciferase-transfected HCT 116 cells (2×10⁶) in PBS (50 μl) were injected subcutaneously into the leg of each mouse with a 27-gauge needle. | |||
Result | Our findings suggest that γ-T3 inhibited the growth of human CRC and sensitised CRC to capecitabine by regulating proteins linked to tumourigenesis. |
Pair Name | Gamma-Tocotrienol, Docetaxel | |||
Partner Name | Docetaxel | |||
Disease Info | [ICD-11: 2B66.Z] | Oral cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | APAF1 | hsa317 |
Down-regulation | Expression | BCL2 | hsa596 | |
Down-regulation | Expression | BIRC2 | hsa329 | |
Down-regulation | Expression | BIRC3 | hsa330 | |
Down-regulation | Expression | BIRC5 | hsa332 | |
Up-regulation | Activity | CASP3 | hsa836 | |
Up-regulation | Activity | CASP8 | hsa841 | |
Up-regulation | Activity | CASP9 | hsa842 | |
Up-regulation | Expression | CYCS | hsa54205 | |
Down-regulation | Expression | NFKB1 | hsa4790 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Down-regulation | Expression | RELA | hsa5970 | |
Down-regulation | Expression | XIAP | hsa331 | |
In Vitro Model | B88 | Metastatic human oral cancer cell | Homo sapiens (Human) | N.A. |
Result | These findings suggest that the combination treatment with these agents may provide enhanced therapeutic response in oral cancer patients, while avoiding the toxicity associated with high-dose β-tubulin stabilization monotherapy. |
Pair Name | Gamma-Tocotrienol, Cisplatin | |||
Partner Name | Cisplatin | |||
Disease Info | [ICD-11: 2C51] | Mesothelioma | Investigative | |
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Down-regulation | Phosphorylation | BAD | hsa572 | |
In Vitro Model | NCI-H28 | Pleural sarcomatoid mesothelioma | Homo sapiens (Human) | CVCL_1555 |
Result | These results suggest that the combination therapy of cisplatin with TRF is a plausible strategy for achieving tolerance for the chemotherapeutic agent in MM therapy. |
Pair Name | Gamma-Tocotrienol, Simvastatin | |||
Partner Name | Simvastatin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | BCL-xL | hsa598 |
Down-regulation | Expression | BIRC5 | hsa332 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | MYC | hsa4609 | |
Down-regulation | Phosphorylation | STAT3 | hsa6774 | |
In Vitro Model | NCI-ADR-RES | High grade ovarian serous adenocarcinoma | Homo sapiens (Human) | CVCL_1452 |
MCF-7/TAMR-1 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_M436 | |
Result | Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol |
No. | Title | Href |
---|---|---|
1 | Gamma-Tocotrienol Synergistically Promotes the Anti-proliferative and Pro-apoptotic Effects of Etoposide on Breast Cancer Cell Lines. Curr Mol Pharmacol. 2022;15(7):980-986. doi: 10.2174/1874467215666220131095611. | Click |
2 | First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. Clin Cancer Res. 2012 Apr 15;18(8):2220-9. doi: 10.1158/1078-0432.CCR-11-2470. | Click |
3 | Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration. Cell Prolif. 2013 Oct;46(5):538-53. doi: 10.1111/cpr.12059. | Click |
4 | {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment. Cancer Res. 2010 Nov 1;70(21):8695-705. doi: 10.1158/0008-5472.CAN-10-2318. Epub 2010 Sep 23. | Click |
5 | γ-Tocotrienol suppresses growth and sensitises human colorectal tumours to capecitabine in a nude mouse xenograft model by down-regulating multiple molecules. Br J Cancer. 2016 Sep 27;115(7):814-24. doi: 10.1038/bjc.2016.257. | Click |
6 | γ-tocotrienol enhances the chemosensitivity of human oral cancer cells to docetaxel through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products. Int J Oncol. 2013;42(1):75-82. doi:10.3892/ijo.2012.1692 through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products. Int J Oncol. 2013;42(1):75-82. doi:10.3892/ijo.2012.1692 | Click |
7 | The tocotrienol-rich fraction from rice bran enhances cisplatin-induced cytotoxicity in human mesothelioma H28 cells. Phytother Res. 2010 Sep;24(9):1317-21. doi: 10.1002/ptr.3107. | Click |
8 | Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol. Cancer Lett. 2013 Jan 28;328(2):285-96. doi: 10.1016/j.canlet.2012.10.003. | Click |